JP2015507002A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015507002A5 JP2015507002A5 JP2014557094A JP2014557094A JP2015507002A5 JP 2015507002 A5 JP2015507002 A5 JP 2015507002A5 JP 2014557094 A JP2014557094 A JP 2014557094A JP 2014557094 A JP2014557094 A JP 2014557094A JP 2015507002 A5 JP2015507002 A5 JP 2015507002A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- weight
- treatment
- enuresis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 18
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims 4
- 208000008967 Enuresis Diseases 0.000 claims 3
- 206010046543 Urinary incontinence Diseases 0.000 claims 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims 2
- 229930003935 flavonoid Natural products 0.000 claims 2
- 150000002215 flavonoids Chemical class 0.000 claims 2
- 235000017173 flavonoids Nutrition 0.000 claims 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims 2
- 235000019156 vitamin B Nutrition 0.000 claims 2
- 239000011720 vitamin B Substances 0.000 claims 2
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 claims 1
- 244000144725 Amygdalus communis Species 0.000 claims 1
- 235000011437 Amygdalus communis Nutrition 0.000 claims 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims 1
- 229920001991 Proanthocyanidin Polymers 0.000 claims 1
- 229930003270 Vitamin B Natural products 0.000 claims 1
- 239000008168 almond oil Substances 0.000 claims 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 229960001231 choline Drugs 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims 1
- 150000003248 quinolines Chemical group 0.000 claims 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims 1
- 235000005493 rutin Nutrition 0.000 claims 1
- 229960004555 rutoside Drugs 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 229920001864 tannin Polymers 0.000 claims 1
- 235000018553 tannin Nutrition 0.000 claims 1
- 239000001648 tannin Substances 0.000 claims 1
- 229940042585 tocopherol acetate Drugs 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP201230242 | 2012-02-15 | ||
| ES201230242A ES2423254B1 (es) | 2012-02-15 | 2012-02-15 | Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis |
| PCT/ES2013/070022 WO2013121061A1 (es) | 2012-02-15 | 2013-01-22 | Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015507002A JP2015507002A (ja) | 2015-03-05 |
| JP2015507002A5 true JP2015507002A5 (enExample) | 2016-03-24 |
| JP6203761B2 JP6203761B2 (ja) | 2017-09-27 |
Family
ID=48983578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014557094A Expired - Fee Related JP6203761B2 (ja) | 2012-02-15 | 2013-01-22 | 尿失禁及び遺尿の処置のための医薬組成物 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9272011B2 (enExample) |
| EP (1) | EP2815755A4 (enExample) |
| JP (1) | JP6203761B2 (enExample) |
| KR (1) | KR20140127874A (enExample) |
| CN (1) | CN104254338B (enExample) |
| AU (1) | AU2013220284A1 (enExample) |
| BR (1) | BR112014020154A8 (enExample) |
| CA (1) | CA2864426A1 (enExample) |
| CL (1) | CL2014002128A1 (enExample) |
| CO (1) | CO7141408A2 (enExample) |
| CR (1) | CR20140419A (enExample) |
| EA (1) | EA028184B1 (enExample) |
| ES (1) | ES2423254B1 (enExample) |
| IL (1) | IL233978A0 (enExample) |
| MA (1) | MA37324A1 (enExample) |
| MX (1) | MX367671B (enExample) |
| PE (1) | PE20142324A1 (enExample) |
| PH (1) | PH12014501823A1 (enExample) |
| WO (1) | WO2013121061A1 (enExample) |
| ZA (1) | ZA201406668B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110339316B (zh) * | 2019-08-09 | 2021-09-21 | 河南中医药大学 | 一种治疗中风后尿失禁的中药 |
| CN116036153B (zh) * | 2023-02-22 | 2023-09-26 | 深圳市儿童医院 | 啤酒花提取物在制备用于治疗或者预防抑郁症、抑郁症并发症、焦虑症的产品中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9137091A (en) | 1990-11-27 | 1992-06-25 | Northwestern University | Gaba and l-glutamic acid analogs for antiseizure treatment |
| AU677008B2 (en) | 1992-05-20 | 1997-04-10 | Northwestern University | Gaba and L-glutamic acid analogs for antiseizure treatment |
| AU779262B2 (en) * | 1999-04-08 | 2005-01-13 | Warner-Lambert Company | Method for the treatment of incontinence |
| FR2823672B1 (fr) * | 2001-04-23 | 2004-03-12 | Berkem Sa | Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes |
| JP2003088335A (ja) * | 2001-09-14 | 2003-03-25 | Pharmafoods Kenkyusho:Kk | 排尿機能改善用食品組成物及びそれを含有する飲食品 |
| GB0306568D0 (en) * | 2003-03-21 | 2003-04-30 | Unilever Plc | Compositions of natural products and use thereof |
| NZ526350A (en) * | 2003-06-09 | 2004-10-29 | A | Anti-aging compositions comprising an amino acid, vitamin B complex, metal salt and an amino alcohol |
| ZA200601975B (en) * | 2003-09-11 | 2007-05-30 | Xenoport Inc | Treating and/or preventing urinary incontinence using prodrugs of GABA analogs |
| JP4815558B2 (ja) * | 2003-10-09 | 2011-11-16 | パシフィック アロー リミテッド | Ｘａｎｔｈｏｃｅｒａｓｓｏｒｂｉｆｏｌｉａ抽出物を含む組成物、該抽出物から単離された化合物、それらを調製する方法、およびそれらの使用 |
| US20070116839A1 (en) * | 2005-11-23 | 2007-05-24 | The Coca-Cola Company | High-Potency Sweetener Composition With C-Reactive Protein Reducing Substance and Compositions Sweetened Therewith |
| EP1889612A3 (en) * | 2006-07-24 | 2008-03-19 | Jan Kees Piet Bruinstroop | Method for controlling micturition |
| US20090180999A1 (en) * | 2008-01-11 | 2009-07-16 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition |
-
2012
- 2012-02-15 ES ES201230242A patent/ES2423254B1/es active Active
-
2013
- 2013-01-22 JP JP2014557094A patent/JP6203761B2/ja not_active Expired - Fee Related
- 2013-01-22 MA MA37324A patent/MA37324A1/fr unknown
- 2013-01-22 MX MX2014009464A patent/MX367671B/es active IP Right Grant
- 2013-01-22 PE PE2014001275A patent/PE20142324A1/es not_active Application Discontinuation
- 2013-01-22 WO PCT/ES2013/070022 patent/WO2013121061A1/es not_active Ceased
- 2013-01-22 EA EA201491437A patent/EA028184B1/ru not_active IP Right Cessation
- 2013-01-22 KR KR1020147025535A patent/KR20140127874A/ko not_active Withdrawn
- 2013-01-22 EP EP13749059.5A patent/EP2815755A4/en not_active Ceased
- 2013-01-22 AU AU2013220284A patent/AU2013220284A1/en not_active Abandoned
- 2013-01-22 CA CA2864426A patent/CA2864426A1/en not_active Abandoned
- 2013-01-22 US US14/378,380 patent/US9272011B2/en not_active Expired - Fee Related
- 2013-01-22 CN CN201380009507.7A patent/CN104254338B/zh not_active Expired - Fee Related
- 2013-01-22 BR BR112014020154A patent/BR112014020154A8/pt not_active Application Discontinuation
-
2014
- 2014-08-06 IL IL233978A patent/IL233978A0/en unknown
- 2014-08-12 PH PH12014501823A patent/PH12014501823A1/en unknown
- 2014-08-12 CL CL2014002128A patent/CL2014002128A1/es unknown
- 2014-09-10 CO CO14200440A patent/CO7141408A2/es unknown
- 2014-09-11 ZA ZA2014/06668A patent/ZA201406668B/en unknown
- 2014-09-12 CR CR20140419A patent/CR20140419A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012236834A5 (enExample) | ||
| HRP20170868T1 (hr) | Liječenje alergije na kikiriki | |
| WO2017037594A2 (zh) | 用于减少局部脂肪的医药组成物及其用途 | |
| HRP20180007T1 (hr) | Formulacija koja sadrži gemcitabin-predlijek | |
| HRP20240115T1 (hr) | Povećavanje bioraspoloživosti lijeka u terapiji naltreksonom | |
| HRP20210010T1 (hr) | Injekcijske farmaceutske formulacije lefamulina | |
| JP2011513340A5 (enExample) | ||
| CN104940163A (zh) | 一种胶囊壳体 | |
| JP2018039810A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2015507002A5 (enExample) | ||
| US20220143126A1 (en) | Synergistic combination of phytoactives | |
| KR102419769B1 (ko) | 약물 조성물 | |
| JP2016514706A5 (enExample) | ||
| ES2795104T3 (es) | Fenoles vegetales y su uso en el tratamiento o la prevención de la esofagitis eosinofílica | |
| CN102631373A (zh) | 一种快速治疗口腔溃疡的药物香口胶 | |
| JP2012041314A5 (enExample) | ||
| RU2014146562A (ru) | Композиция, содержащая альфа-липоевую кислоту и гонокиол, для лечения нейропатий | |
| CN104161763A (zh) | 一种药物组合物作为制备治疗皮炎湿疹中的应用 | |
| CN105555289B (zh) | 可可多酚及其在治疗或预防嗜酸性食管炎中的效用 | |
| CN111315376A (zh) | 用于在治疗子宫内膜异位症和子宫内膜异位症相关症状中使用的物质和组合物 | |
| WO2011108882A3 (ko) | 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물 | |
| EP3097921A1 (en) | Composition comprising active ingredients of vegetable origin | |
| WO2011093811A3 (en) | Pharmaceutical preparations comprising formoterol and fluticasone | |
| CN101732301A (zh) | 绿原酸在制备防治老年性痴呆的药中的应用 |